-
Vanda Pharmaceuticals Sets Date for Q3 2026 Financial Results
NASDAQ: $VNDA Mark Your Calendars: Q3 2026 Financial Update Vanda Pharmaceuticals Inc. has officially announced that it will release its financial results for the third quarter of 2026 on Wednesday, October 28, 2026. This upcoming disclosure is a key event for investors and stakeholders looking to gauge the company’s performance throughout the quarter. How to…
-
A Breakthrough for Circadian Rhythm: Vanda Pharmaceuticals Reports Positive Phase III Results
New Hope for Delayed Sleep-Wake Phase Disorder Vanda Pharmaceuticals has reached a significant milestone in sleep medicine. The company recently announced positive results from its Phase III clinical trial evaluating Hetlioz (tasimelteon) for the treatment of Delayed Sleep-Wake Phase Disorder (DSWPD). Understanding DSWPD Delayed Sleep-Wake Phase Disorder is a chronic circadian rhythm disorder characterized by…